Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Study Information
Alliance Study ID: ACOSOG-Z4031
NCT Study ID (ClinicalTrials.gov): NCT00077324
Disease or Cancer Type: Lung Cancer & Mesothelioma
Alliance Study Chair: David H. Harpole, MD
Status: COMPLETED
Study Description
RATIONALE: Evaluating specific proteins in the blood may be an effective and noninvasive procedure to help doctors determine if a patient has early non-small cell lung cancer.
PURPOSE: This clinical trial is studying proteomic profiling to see how well it works in diagnosing non-small cell lung cancer in patients who are undergoing resection for suspicious (abnormal) stage I lung lesions.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information